Mar 20, 2023 | Laboratory Mergers and Acquisitions, Laboratory News, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing, Precision Medicine
Loss could indicate an industrywide slowdown in digital health adoption and suggests medical laboratories will want to continue developing a virtual care strategy Only two years after Teladoc Health (NYSE:TDOC) completed acquisition of Livongo, a data-based health coaching company, the virtual healthcare provider reported a 2022 net loss of $13.7 billion, a company press release announced. The loss, which has been described as “historic,” is “mostly from a write-off related to the plummeting...
Mar 15, 2023 | Clinical Laboratory Middleware, Informatics, Analytics, Digital Pathology, Lab and Pathology Mergers, Acquisitions, Valuations, Laboratory Sales and Marketing, Laboratory Testing, Pathology and Clinical Laboratory Conferences
Clarapath is working to automate manual processes in histology while also capturing data to better inform clinical laboratories Looking to provide an end-to-end digital pathology solution, medical robotics maker Clarapath has acquired Crosscope, a medical artificial intelligence (AI) software company that develops AI-powered telepathology for medical image information extraction and precision medicine diagnostics. The deal will enable Crosscope’s digital pathology platform to layer around...
Feb 27, 2023 | Compliance, Legal, and Malpractice, Laboratory Pathology, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing
Supporters of the VALID Act say lobbying blitz by academic medical centers prevented its passage In 2022, a bill before Congress titled the Verifying Accurate Leading-Edge IVCT Development Act (VALID Act) sought to change the current regulatory scheme for clinical laboratory-developed tests (LDTs) and in vitro clinical tests (IVCTs). But even though the College of American Pathologists (CAP) and nine other organizations signed a December 12 stakeholder letter to leaders of key House and Senate...
Dec 5, 2022 | Laboratory Mergers and Acquisitions, Laboratory News, Laboratory Pathology, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing
Company also launches Amazon Clinic virtual healthcare services and announces it will terminate Amazon Care by end of year Clinical laboratory leaders and pathologists may understandably struggle to keep abreast of Amazon’s moves in the healthcare space. For years, Amazon has tried to develop medical services that disrupt the US healthcare industry in the same way its digital book business upended traditional book publishing. It is clear that Amazon is heavily investing in healthcare ventures...
Mar 8, 2022 | Clinical Laboratory/ Pathology Coding, Billing, and Collection Resources, Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing, Laboratory Testing, News From Dark Daily, Pathology and Clinical Laboratory Conferences
The Department of Justice steps beyond the law’s original focus on opioid-related lab testing fraud An interesting aspect with enforcement of the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) is the government’s willingness to go after charges tied to fraudulent COVID-19 testing. The case U.S. vs. Malena Badon Lepetich provides a good example of this approach. A grand jury indicted Lepetich on various healthcare fraud charges last year, including that she allegedly offered to pay...
Jan 21, 2022 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, International Laboratory News, Laboratory News, Laboratory Pathology, Laboratory Sales and Marketing, Laboratory Testing
In an out-of-court settlement, two commercial clinical laboratory companies also agreed to reduce their prices for rapid antigen tests as well How clinical laboratory companies were pricing their COVID-19 tests caught the attention of government authorities in South Africa. Government agencies in that country are establishing what they view as fair clinical laboratory pricing for private COVID-19 PCR (polymerase chain reaction) and rapid antigen tests without turning to litigation or fines....
